Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters
- 1 May 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 78 (5) , 737-741
- https://doi.org/10.1016/0002-9343(85)90276-1
Abstract
No abstract availableFunding Information
- National Institutes of Health (CA34994)
- U.S. Public Health Service (R07439)
This publication has 14 references indexed in Scilit:
- Recombinant Alpha-2 Interferon Therapy for Kaposi's Sarcoma Associated with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1984
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983
- Disseminated Kaposi's Sarcoma in Homosexual MenAnnals of Internal Medicine, 1982
- Outbreak of Kaposi's sarcoma with cytomegalovirus infection in young homosexual menThe American Journal of Medicine, 1982
- Interferon: Immunobiology and Clinical SignificanceAnnals of Internal Medicine, 1982
- Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsiesInternational Journal of Cancer, 1981
- KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASESThe Lancet, 1981
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979
- KAPOSIʼS SARCOMA: A CLINICOPATHOLOGIC STUDY WITH PARTICULAR REFERENCE TO ITS RELATIONSHIP TO THE RETICULOENDOTHELIAL SYSTEMMedicine, 1965